Currently Viewing:
Supplements Non-Small Cell Lung Cancer: Clinical and Economic Considerations in Targeting Therapy Based on Molec
Shifting Paradigms in Non-Small Cell Lung Cancer: An Evolving Therapeutic Landscape
Jonathan Riess, MD, MS
Biomarkers and Molecular Profiling in Non-Small Cell Lung Cancer: An Expanding Role and Its Managed Care Implications
Robert T. Adamson, PharmD, FASHP
Currently Reading
Post Test: Non-Small Cell Lung Cancer: Clinical and Economic Considerations in Targeting Therapy Based on Molecular Profiling

Post Test: Non-Small Cell Lung Cancer: Clinical and Economic Considerations in Targeting Therapy Based on Molecular Profiling

Instructions
After reading “Non-Small Cell Lung Cancer: Clinical and Economic Considerations in Targeting Therapy Based on Molecular Profiling,” complete the program evaluation and select the single best answer to each of the posttest questions.

A statement of continuing education credit will be provided to those physicians and pharmacists who successfully complete and return the answer form and program evaluation and receive a passing grade of 70% or higher on the posttest.



Take Physician CME Test


Take Pharmacist CE Test

PDF
 
Copyright AJMC 2006-2017 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!